Robert A. Kyle, M.D.

Chairman of Scientific Advisory Board- Dr. Kyle is Professor of Medicine and Laboratory Medicine at the Mayo Clinic in Rochester, MN. Formerly Chairman of the Division of Hematology. He serves on the Boards and Scientific Advisory Boards of a number of foundations and societies devoted to myeloma and hematological diseases, and is the recipient of numerous awards and honors.

Kenneth C. Anderson, M.D.

Dr. Anderson is Director of the Jerome Lipper Multiple Myeloma Center of the Dana Farber Cancer Institute and Professor of Medicine at Harvard Medical School, Harvard, Boston, Massachusetts.

Moshe Talpaz, M.D. 

Dr. Talpaz is chairman of the Department of Bioimmunotherapy at the University of Texas MD Anderson Cancer Center, Houston, Texas, where he also holds the position of David Burton, Jr. Professor of Medicine and Internist.

Randall Johnson, Ph.D. 

Dr. Johnson has over 20 years experience in drug discovery and development. While at GlaxoSmithKline/SmithKline Beecham, Dr. Johnson held positions of increasing responsibility including Associate Director and Director of Discovery Oncology Research and Group Director of the Department of Oncology Research.